These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 23757939

  • 1. Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs.
    Cytarska J, Misiura K, Filip-Psurska B, Wietrzyk J.
    Acta Pol Pharm; 2013; 70(3):481-7. PubMed ID: 23757939
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
    Roth T, Tang W, Eisenbrand G.
    Anticancer Drug Des; 1995 Dec; 10(8):655-66. PubMed ID: 8595124
    [Abstract] [Full Text] [Related]

  • 3. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M, Fan J, Baturay NZ, Kwon CH.
    J Med Chem; 2004 Jul 15; 47(15):3843-52. PubMed ID: 15239662
    [Abstract] [Full Text] [Related]

  • 4. Isophosphoramide mustard analogues as prodrugs for anticancer gene-directed enzyme-prodrug therapy (GDEPT).
    Misiura K, Szymanowicz D, Kuśnierczyk H, Wietrzyk J, Opolski A.
    Acta Biochim Pol; 2002 Jul 15; 49(1):169-76. PubMed ID: 12136937
    [Abstract] [Full Text] [Related]

  • 5. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH, Moon KY, Baturay N, Shirota FN.
    J Med Chem; 1991 Feb 15; 34(2):588-92. PubMed ID: 1995881
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y, Voissière A, Peyrode C, Galmier MJ, Maubert E, Ghedira D, Tarrit S, Gaumet V, Canitrot D, Miot-Noirault E, Chezal JM, Weber V.
    Bioorg Chem; 2020 May 15; 98():103747. PubMed ID: 32208207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
    Hernick M, Flader C, Borch RF.
    J Med Chem; 2002 Aug 01; 45(16):3540-8. PubMed ID: 12139465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy.
    Hu L, Yu C, Jiang Y, Han J, Li Z, Browne P, Race PR, Knox RJ, Searle PF, Hyde EI.
    J Med Chem; 2003 Nov 06; 46(23):4818-21. PubMed ID: 14584930
    [Abstract] [Full Text] [Related]

  • 13. Phosphate prodrugs of isophosphoramide mustard.
    Misiura K, Szymanowicz D, Wietrzyk J, Opolski A.
    Acta Pol Pharm; 2003 Nov 06; 60(2):109-12. PubMed ID: 13678316
    [Abstract] [Full Text] [Related]

  • 14. An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation.
    Adidala R, Devalapally H, Srivari C, Devarakonda R K, Akkinepally RR.
    Drug Dev Ind Pharm; 2012 Sep 06; 38(9):1047-53. PubMed ID: 22185667
    [Abstract] [Full Text] [Related]

  • 15. Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept.
    Skarbek C, Lesueur LL, Chapuis H, Deroussent A, Pioche Durieu C, Daville A, Caron J, Rivard M, Martens T, Bertrand JR, Le Cam E, Vassal G, Couvreur P, Desmaele D, Paci A.
    J Med Chem; 2015 Jan 22; 58(2):705-17. PubMed ID: 25494842
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ, Farquhar D.
    J Med Chem; 1991 Jan 22; 34(1):197-203. PubMed ID: 1992116
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF, Schmid SM, Waud WR.
    Cancer Chemother Pharmacol; 1994 Jan 22; 34(3):191-6. PubMed ID: 8004750
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.